Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Head and neck cancer survivors' preferences for and evaluations of a post-treatment dietary intervention 2019
2019 Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials 2019
2019 Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study 2019
2019 Feasibility Outcomes of a Pilot Randomized Clinical Trial to Increase Cruciferous and Green Leafy Vegetable Intake in Posttreatment Head and Neck Cancer Survivors 2019
2019 Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial 2019
2019 Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study 2019
2019 Electromagnetic Transponder Based Tracking and Gating in the Radiotherapeutic Treatment of Thoracic Malignancies 2019
2019 Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy 2019
2019 Repeat gamma knife stereotactic radiosurgery in the treatment of trigeminal neuralgia: A single-center experience and focused review of the literature 2019
2018 First-line treatment of widely metastatic BRAF-mutated salivary duct carcinoma with combined BRAF and MEK inhibition 2018
2018 Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study 2018
2018 Head and neck cancers: Advantages of advanced radiation therapy and importance of supportive care 2018
2018 NCCN guidelines ® insights: Head and neck cancers, version 1.2018 featured updates to the NCCN guidelines 2018
2017 NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017 2017
2017 In reply 2017
2016 Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neck 2016
2016 Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234) 2016
2016 Smoking cessation, version 1.2016 clinical practice guidelines in oncology 2016
2016 Analysis of Predictive Factors for Acute Esophagitis in Lung Cancer Radiation Therapy. 2016
2016 Analysis of Predictive Factors for Pneumonitis in Lung Cancer Radiation Therapy. 2016
2016 Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial 2016
2016 Cetuximab and radiotherapy in laryngeal preservation for cancers of the larynx and hypopharynx a secondary analysis of a randomized clinical trial 2016
2016 Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience 2016
2016 A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases 2016
2015 Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines 2015
2015 Evaluation of 3M™ molecular detection assay (MDA) Listeria for the detection of Listeria species in selected foods and environmental surfaces: Collaborative study, first action 2014.06 2015
2015 Evaluation of 3M™ molecular detection assay (MDA) Listeria monocytogenes for the detection of Listeria monocytogenes in selected foods and environmental surfaces: Collaborative study, first action 2014.07 2015
2014 Head and neck cancers, version 2.2014 2014
2014 Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303) 2014
2014 Pazopanib combined with radiation: In vivo model of interaction 2014
2014 Final results of local-regional control and late toxicity of rtog 9003: A randomized trial of altered fractionation radiation for locally advanced head and neck cancer 2014
2014 African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis 2014
2014 A technique using 99mTc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastases 2014
2014 Comparison of plan quality and delivery time between volumetric arc therapy (rapidarc) and gamma knife radiosurgery for multiple cranial metastases 2014
2013 Stereotactic body radiation therapy (SBRT) for lung malignancies: Preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute 2013
2013 Head and Neck Cancers, version 2.2013 2013
2013 Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma 2013
2013 Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer; The university of alabama at birmingham experience 2013
2013 Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer 2013
2013 Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy 2013
2013 Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy 2013
2012 Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies 2012
2012 Influenza immunization in older adults with and without cancer 2012
2012 Plan quality and treatment planning technique for single isocenter cranial radiosurgery with volumetric modulated arc therapy 2012
2012 Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer 2012
2012 Mucosal melanoma of the head and neck 2012
2012 Mucosal melanoma: A clinically and biologically unique disease entity 2012
2012 SU‐E‐T‐434: Use of Deformable Registration for Cumulated Dose Calculation in Image‐Guided Intracavitary Bracytherapy for Cervical Cancer 2012
2011 Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer 2011
2011 Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx 2011
2011 Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma 2011
2011 Radiation-induced ocular motor cranial nerve palsies in patients with pituitary tumor 2011
2011 Head and neck cancers: Clinical practice guidelines in oncology 2011
2011 Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with Radiation Therapy (RTOG 9003) 2011
2011 Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy 2011
2011 Improved clinical efficiency in CNS stereotactic radiosurgery using a flattening filter free linear accelerator. 2011
2010 Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck 2010
2010 Effects of Bladder Distension on Organs at Risk in 3D Image-Based Planning of Intracavitary Brachytherapy for Cervical Cancer 2010
2010 Margin on Gross Tumor Volume and Risk of Local Recurrence in Head-and-Neck Cancer 2010
2010 Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival 2010
2009 Postoperative reirradiation for mucosal head and neck squamous cell carcinomas 2009
2009 Development of an accelerated GVF semi-automatic contouring algorithm for radiotherapy treatment planning 2009
2009 NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer 2009
2009 Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer 2009
2008 Reirradiation and concurrent chemotherapy after salvage surgery: Pay now or pay later 2008
2008 Head and neck cancers 2008
2008 Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment 2008
2008 Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck 2008
2008 Pretreatment Quality of Life Predicts for Locoregional Control in Head and Neck Cancer Patients: A Radiation Therapy Oncology Group Analysis 2008
2008 Predictors of Distant Brain Recurrence for Patients With Newly Diagnosed Brain Metastases Treated With Stereotactic Radiosurgery Alone 2008
2007 SU‐FF‐J‐78: 3‐D Target Localization at the End of Expiration Prior to Respiration‐Gated Radiotherapy Treatment 2007
2007 SU‐FF‐T‐372: Registration of Frameless High‐Field MRI to Low‐Field Frame‐Based MRI Images in Leksell Gamma‐Knife (LGK) Radiosurgery 2007
2007 SU‐FF‐T‐426: Treatment Planning Comparison of Dynamic Multileaf Collimation and Helical Tomotherapy for Spinal Cord Sparing in Head and Neck Re‐Irradiation 2007
2006 Disadvantage of men living alone participating in radiation therapy oncology group head and neck trials 2006
2006 Postoperative radiotherapy in non-small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy 2006
2006 An IMRT technique to increase therapeutic ratio of breast irradiation in patients with early stage left breast cancer: Limiting second malignancies. 2006
2006 The authors and a colleague reply [11] 2006
2006 Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience 2006
2006 Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men 2006
2005 Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14 2005
2005 Pulmonary resection after high-dose and low-dose chest irradiation 2005
2005 Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer 2005
2005 Is there disparity in the care of minority patients with upper aerodigestive tract malignancy? 2005
2005 Monte Carlo techniques for scattering foil design and dosimetry in total skin electron irradiations. 2005
2005 Head and neck cancers: Clinical practice guidelines 2005
2005 Monte Carlo techniques for scattering foil design and dosimetry in total skin electron irradiations 2005
2005 SU‐FF‐J‐123: Residual Tumor Motion in Respiratory Gated CT Treatment Planing 2005
2005 SU‐FF‐T‐282: Beam Modifier Design for Total Skin Electron Irradiations Using Monte Carlo Techniques 2005
2005 Simultaneous optimization of sequential IMRT plans 2005
2004 A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT 2004
2003 Docetaxel with concurrent radiotherapy in head and neck cancer. 2003
2003 Role of radiation therapy and radiosurgery in glioblastoma multiforme 2003
2003 Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer 2003
2003 Validation of target volume and position in respiratory gated CT planning and treatment 2003
2002 Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: Long-term follow-up of a phase I trial 2002
2001 RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck 2001
2001 Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer 2001
2000 Tumor shrinkage before intracavitary brachytherapy for cancer of the cervix: Radiotherapy alone versus concurrent chemoradiotherapy 2000
2000 Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. 2000
2000 A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 2000
2000 A prospective evaluation of the timing of postoperative radiotherapy for preventing heterotopic ossification following traumatic acetabular fractures 2000
2000 A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer 2000
2000 NCCN Practice Guidelines for Head and Neck Cancers. 2000
1999 UFT/oral calcium folinate plus radiation in pancreatic cancer. 1999
1999 Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer 1999
1999 Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01) 1999
1999 Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: Preliminary results of two pilot trials using paclitaxel and cisplatin 1999
1999 Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy m locally advanced non-small cell lung cancer: Analysis of early and late pulmonary morbidity 1999
1999 Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck 1999
1998 Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: A multicenter pilot study 1998
1997 Sucralfate for radiation mucositis: Results of a double-blind randomized trial 1997
1997 An umbilical metastasis after laparoscopy for squamous cell carcinoma of the cervix 1997
1996 Major geometric variations between intracavitary applications in carcinoma of the cervix: High dose rate vs. Low dose rate 1996
1996 Postsurgical recurrent carcinoma of the cervix: Reassessment and results of radiation therapy options 1996
1995 Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer 1995
1995 Cisplatin plus radiation therapy. 1995
1995 Conventional four-field pelvic radiotherapy technique without computed tomography-treatment planning in cancer of the cervix: Potential geographic miss and its impact on pelvic control 1995
1995 Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: Frequency and types of variation 1995
1994 A clinically practical electron cone for the treatment of head and neck cancer 1994
1994 Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: potential geographic miss 1994
1993 Malignant epidural spinal cord compression associated with a paravertebral mass: Its radiotherapeutic outcome on radiosensitivity 1993
1993 The influence of staging laparotomy for cervical cancer on patterns of recurrence and survival. 1993
1993 The influence of staging laparotomy for on patterns of recurrence and survival cervical cancer 1993
1992 A Phase I study of high-dose cisplatin, prolonged infusion 5- fluorouracil, and concomitant conventional fraction radiation therapy in patients with inoperable squamous cell carcinoma of the head and neck 1992
1992 Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation 1992
1991 A phase I study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neck 1991
1991 Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody 1991
1991 Three-port perineal sparing technique 1991
1990 Extradural spinal cord compression: Analysis of factors determining functional prognosis - Prospective study 1990

Chapter

Year Title Altmetric
2010 Impact of dose rate on outcomes of Gamma Knife® radiosurgery in patients with face pain.  360-365. 2010

Principal Investigator On

Education And Training

  • UAB Hospital, Internship 1984
  • UAB Hospital, Residency 1987
  • Full Name

  • Sharon Spencer